LHC Group (NASDAQ:LHCG) Stock Rating Reaffirmed by William Blair

William Blair reissued their outperform rating on shares of LHC Group (NASDAQ:LHCG) in a report published on Tuesday, November 21st.

LHCG has been the topic of a number of other reports. Oppenheimer lifted their price target on LHC Group from $68.00 to $80.00 and gave the stock an outperform rating in a research note on Tuesday, November 7th. Royal Bank Of Canada reissued a buy rating and set a $70.00 price objective on shares of LHC Group in a research note on Wednesday, September 6th. Jefferies Group boosted their price objective on LHC Group from $68.00 to $83.00 and gave the stock a buy rating in a research note on Tuesday, November 7th. They noted that the move was a valuation call. Zacks Investment Research lowered LHC Group from a buy rating to a hold rating in a research note on Friday, November 10th. Finally, SunTrust Banks reissued a buy rating and set a $75.00 price objective on shares of LHC Group in a research note on Friday, November 3rd. Three equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The company presently has a consensus rating of Buy and a consensus target price of $77.10.

LHC Group (LHCG) traded up $0.01 during trading on Tuesday, hitting $63.91. The stock had a trading volume of 326,390 shares, compared to its average volume of 148,853. The stock has a market capitalization of $1,150.85, a PE ratio of 27.02, a PEG ratio of 1.87 and a beta of 0.69. LHC Group has a 1-year low of $41.66 and a 1-year high of $76.14. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Monday, November 6th. The health services provider reported $0.64 EPS for the quarter, beating the Zacks’ consensus estimate of $0.60 by $0.04. The business had revenue of $272.90 million during the quarter, compared to analysts’ expectations of $265.35 million. LHC Group had a return on equity of 9.52% and a net margin of 4.09%. The business’s revenue was up 18.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.54 earnings per share. equities analysts forecast that LHC Group will post 2.4 EPS for the current fiscal year.

In other news, COO Donald Dwayne Stelly sold 2,650 shares of the company’s stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $65.34, for a total transaction of $173,151.00. Following the completion of the transaction, the chief operating officer now directly owns 109,235 shares of the company’s stock, valued at approximately $7,137,414.90. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 14.80% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in LHCG. BlackRock Inc. boosted its position in shares of LHC Group by 43,223.7% in the 1st quarter. BlackRock Inc. now owns 1,969,496 shares of the health services provider’s stock valued at $106,157,000 after purchasing an additional 1,964,950 shares during the period. Royal Bank of Canada boosted its position in shares of LHC Group by 50,943.5% in the 2nd quarter. Royal Bank of Canada now owns 165,381 shares of the health services provider’s stock valued at $11,229,000 after purchasing an additional 165,057 shares during the period. Castleark Management LLC acquired a new stake in shares of LHC Group in the 2nd quarter valued at about $7,661,000. AJO LP acquired a new stake in shares of LHC Group in the 2nd quarter valued at about $6,300,000. Finally, Robeco Institutional Asset Management B.V. acquired a new stake in shares of LHC Group in the 3rd quarter valued at about $5,197,000. 85.51% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This news story was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2017/12/07/lhc-group-lhcg-coverage-initiated-by-analysts-at-william-blair.html.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply